At-A-Glance Session Detail
   
MR-Guided Interventions
Weekday Course
ORGANIZERS: Shoko Hara, Harpreet Hyare, Nadya Pyatigorskaya, Allen Song, Wietske van der Zwaag
Wednesday, 14 May 2025
311
13:30 -  15:30
Moderators: Salil Soman & Holden Wu
Skill Level: Intermediate to Advanced
Session Number: W-02
CME Credit

Session Number: W-02

Overview
This course will explore advanced MRI-guided interventions, focusing on techniques such as LIFU, HIFU, TMS, and TDCS. Participants will gain insights into their principles, clinical applications, and the latest research developments, enhancing their ability to utilize these technologies in scientific and clinical settings.

Target Audience
Scientists and clinicians interested in MRI-guided interventions and new potentials of MRI.



Educational Objectives
As a result of attending this course, participants should be able to:
• Discuss the principles and applications of MRI-guided LIFU and HIFU;
• Evaluate the efficacy and potential of MRI-guided neuromodulation techniques; and
• Assess the clinical outcomes and advancements in blood-brain barrier (BB) opening techniques.

13:30 Advancements in LIFU: Therapeutic Potential & Clinical Applications
TBD
14:00 Innovations in Blood-Brain Barrier Opening with Focused Ultrasound (FUS)
TBD
14:30 Advances in Neuromodulation Techniques
Jean-Francois Aubry
15:00HIFU in Brain Therapy: General Concept & Applications to ET & PD Treatment
Meiyun Wang

Keywords: Neuro: Brain

This talk introduces the general concept of Magnetic Resonance-guided Focused Ultrasound (MRgFUS) and research progress in using MRgFUS for Parkinson's disease (PD) and essential tremor (ET) treatment. For high intensity MRgFUS ablation, the most commonly used target for PD and ET treatment is the ventral intermediate nucleus. Additionally, in the case of PD treatment with MRgFUS, other targets such as the globus pallidus and subthalamic nucleus could also be selected. Low-intensity MRgFUS for blood-brain barrier (BBB) opening and neuromodulation represents highly promising therapeutic approaches. BBB opening can facilitate drug delivery, while neuromodulation may induce changes in neurotransmitter levels.